Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TREMELIMUMAB\TREMELIMUMAB-ACTL vs TREPROSTINIL: Safety Overview

Metric TREMELIMUMAB\TREMELIMUMAB-ACTL TREPROSTINIL
Total FAERS Reports 1,173 91,795
Deaths Reported 328 8,865
Death Rate 28.0% 9.7%
Hospitalizations 428 35,507
Average Patient Age 71.1 yrs 58.6 yrs
% Female Patients 18.5% 73.2%
FDA Approval Date N/A Feb 11, 2021
Manufacturer N/A United Therapeutics Corporation
Route N/A ORAL
Marketing Status N/A Prescription